Advanced search
Publication Cover
Nutrition and Dietary Supplements Volume 10, 2018 - Issue
Submit an article Journal homepage
304
Views
6
CrossRef citations to date
0
Altmetric
Review

Role of nutrients in metabolic syndrome: a 2017 update

Hua J KernThe Nature’s Bounty Co., Ronkonkoma, NY, USACorrespondence[email protected]
&
Susan Hazels MitmesserThe Nature’s Bounty Co., Ronkonkoma, NY, USA
Pages 13-26 | Published online: 28 Feb 2018

References

  • McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011;12(5):333–340.
  • Udenigwe CC, Rouvinen-Watt K. The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions. Int J Mol Sci. 2015;16(5):9303–9313.
  • Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. National Health Statistics Reports; no 13. Hyattsville, MD: National Center for Health Statistics. 2009.
  • Phillips CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013;5(1):32–57.
  • Writing Group Members; Mozzafarian D, Benjamin EJ, et al. Heart Disease And Stroke Statistics-2016 Update: a report from the American Heart Association. Circulation. 2016;133:e38–e360.
  • Centers for Disease Control and Prevention. National Diabetes Statistics Report 2014. Atlanta, GA: Centers for Disease Control and Prevention,US Department of Health and Human Services. 2017.
  • DeVol R, Bedroussian A. Research report: an unhealthy America: the economic burden of chronic disease. Santa Monica CA: Milken Institute. 2017. Available at: http://www.milkeninstitute.org/publications/view/321.
  • Brenseke B, Prater MR, Bahamonde J, Gutierrez JC. Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome. J Pregnancy. 2013;2013:368461.
  • Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015; 101 (Suppl):1320S–9S.
  • Keller U. Dietary proteins in obesity and in diabetes. Int J Vitam Nutr Res. 2011;81(2–3): 125–133.
  • Newsholme P, Cruzat V, Arfuso F, Keane K. Nutrient regulation of insulin secretion and action. J Endocrinol. 2014;221(3):R105–R120.
  • Dugan CE, Fernandez ML. Effects of dairy on metabolic syndrome parameters: a review. Yale J Biol Med. 2014;87(2):135–147.
  • Calton EK, James AP, Pannu PK, Soares MJ. Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence. Nutr Res. 2014;34(7):559–568.
  • Davi G, Santilli F, Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther. 2010;28(4):216–226.
  • Roche HM. Fatty acids and the metabolic syndrome. Proc Nutr Soc. 2005;64(1):23–29.
  • Whayne TF Jr, Maulik N. Nutrition and the healthy heart with an exercise boost. Can J Physiol Pharmacol. 2012;90(8):967–976.
  • Malik P, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33(11):2477–2483.
  • Renwick AG, Molinary SV. Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release. Br J Nutr. 2010;104:1415–1420.
  • Avignon A, Hokayem M, Bisbal C, Lambert K. Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism? Nutrition. 2012;28(7–8):715–721.
  • Dakshinamurti K. Vitamins and their derivatives in the prevention and treatment of metabolic syndrome diseases (diabetes). Can J Physiol Pharmacol. 2015;93(5):355–362.
  • Xu YJ, Tappia PS, Neki NS, Dhalla NS. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail Rev. 2014;19(1):113–121.
  • Makariou S, Liberopoulos EN, Elisaf M, Challa A. Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med. 2011;22(4):355–362.
  • Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition. 2011;27(9):868–879.
  • Cosenso-Martin LN, Vilela-Martin JF. Is there an association between vitamin D and hypertension? Recent Pat Cardiovasc Drug Discov. 2011;6(2):140–147.
  • Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008;34(6):939–940, 942, 944 passim.
  • Mozos I, Marginean O. Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int. 2015;2015:109275.
  • Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc. 2013;72(1):89–97.
  • Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–2029.
  • Ju SY, Jeong HS, Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab. 2014;99(3):1053–1063.
  • Barengolts E. Vitamin D role and use in prediabetes. Endocr Pract. 2010;16(3):476–485.
  • Garbossa SG, Folli F. Vitamin D, sub-inflammation and insulin resistance: a window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord 2017;18:243–258.
  • da Silva RP, Kelly KB, Al Rajabi A, Jacobs RL. Novel insights on interactions between folate and lipid metabolism. Biofactors. 2014;40(3):277–283.
  • Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. 2009;80(2):157–162.
  • Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure-a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324–333.
  • Floege J. Magnesium in CKD: more than a calcification inhibitor? J Nephrol. 2015;28(3):269–277.
  • Volpe SL. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr. 2008;48(3):293–300.
  • He K, Song Y, Belin RJ, Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr. 2006;1(5):351–355.
  • Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res. 2007;39(10):743–751.
  • Azhar Y, Parmar A, Miller CN, Samuels JS, Rayalam S. Phytochemicals as novel agents for the induction of browning in white adipose tissue. Nutr Metab (Lond). 2016;13:89.
  • Santana-Galvez J, Cisneros-Zevallos L, Jacobo-Velazquez DA. Chlorogenic acid: recent advances on its dual role as a food additive and a nutraceutical against metabolic syndrome. Molecules. 2017;22(3):pii:E358.
  • Maeda H. Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review. J Oleo Sci. 2015;64(2):125–132.
  • Millan J, Cicero AFG, Torres F, Anguera A. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta-analysis of randomized controlled trials. Clin Investig Arterioscler. 2016;28(4):178–187.
  • Ribas-Latre A, Eckel-Mahan K. Interdependence of nutrient metabolism and the circadian clock system: importance for metabolic health. Mol Metab. 2016;5(3):133–152.
  • Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond). 2015;39(4):633–641.
  • Tarrade A, Panchenko P, Junien C, Gabory A. Placental contribution to nutritional programming of health and diseases: epigenetics and sexual dimorphism. J Exp Biol. 2015;218(Pt 1):50–58.
  • Brenseke B, Prater MR, Bahamonde J, Gutierrez JC. Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome. J Pregnancy. 2013;2013:368461.
  • Knip M, Akerblom HK. Early nutrition and later diabetes risk. Adv Exp Med Biol. 2005;569:142–150.
  • Brown LD. Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health. J Endocrinol. 2014;221(2):R13–R29.
  • DeBoer MD, Lima AA, Oría RB, et al. Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome? Nutr Rev. 2012;70(11):642–653.
  • Alvisi P, Brusa S, Alboresi S, et al. Recommendations on complementary feeding for healthy, full-term infants. Ital J Pediatr. 2015;41:36.

References

  • Udenigwe CC, Rouvinen-Watt K. The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions. Int J Mol Sc. 2015; 16(5):9303–9313.
  • Phillips, CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 2013; 5(1):32–57.
  • Leidy HJ, Clifton PM, Astrup A, Wycherley TP, Westerterp-Plantenga MS, Luscombe-Marsh ND, Woods SC, Mattes RD. The role of protein in weight loss and maintenance. Am J Clin Nutrition 2015; 101 (Suppl):1320S-9S.
  • Keller U. Dietary proteins in obesity and in diabetes. Int J Vitam Nutr Res 2011; 81(2–3):125–133.
  • Newsholme P, Cruzat V, Arfuso F, Keane K. Nutrient regulation of insulin secretion and action. J Endocrinol 2014; 221(3): R105–120.
  • Dugan CE, Fernandez ML. Effects of dairy on metabolic syndrome parameters: a review. Yale J Biol Med 2014; 87(2):135–147.
  • Calton EK, James AP, Pannu PK, Soares MJ. Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence. Nutr Res 2014; 34(7):559–568.
  • Davi G, Santilli F, Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 2010; 28(4):216–226.
  • Roche HM. Fatty acids and the metabolic syndrome. Proc Nutr Soc 2005; 64(1):23–29.
  • Whayne TF Jr., Maulik N. Nutrition and the healthy heart with an exercise boost. Can J Physiol Pharmacol 2012; 90(8):967–976.
  • Malik P, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33(11):2477–83.
  • Renwick AG, Molinary SV. Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release. British Journal of Nutrition 2010; 104:1415–1420.
  • Avignon A, Hokayem M, Bisbal C, Lambert K. Dietary antioxidants: Do they have a role to play in the ongoing fight against abnormal glucose metabolism? Nutrition 2012; 28(7–8):715–721.
  • Dakshinamurti, K. Vitamins and their derivatives in the prevention and treatment of metabolic syndrome diseases (diabetes). Can J Physiol Pharmacol 2015; 93(5):355–362.
  • Xu YJ, Tappia PS, Neki NS, Dhalla NS. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail Rev 2014; 19(1):113–121.
  • Makariou S, Liberopoulos EN, Elisaf M, Challa A. Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med 2011; 22(4):355–362.
  • Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 2011; 27(9):868–879.
  • Cosenso-Martin LN, Vilela-Martin JF. Is there an association between vitamin D and hypertension? Recent Pat Cardiovasc Drug Discov 2011; 6(2):140–147.
  • Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and diabetes: let the sunshine in. Diabetes Educ 2008; 34(6):939–940, 942, 944 passim.
  • Mozos I, Marginean O. Links between Vitamin D Deficiency and Cardiovascular Diseases. Biomed Res Int 2015:109275.
  • Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013; 72(1):89–97.
  • Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92(6):2017–2029.
  • Ju SY, Jeong HS, Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 2014; 99(3):1053–1063.
  • Barengolts E. Vitamin D role and use in prediabetes. Endocr Pract 2010; 16(3):476–485.
  • Garbossa SG, Folli F. Vitamin D, sub-inflammation and insulin resistance: a window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord 2017;18:243–258.
  • da Silva RP, Kelly KB, Al Rajabi A, Jacobs RL. Novel insights on interactions between folate and lipid metabolism. Biofactors 2014; 40(3):277–283.
  • Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician 2009. 80(2):157–162.
  • Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, Song Y. Effects of magnesium supplementation on blood pressure-a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension 2016; 68.
  • Floege J. Magnesium in CKD: more than a calcification inhibitor? J Nephrol 2015; 28(3):269–277.
  • Volpe SL. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr 2008; 48(3):293–300.
  • He K, Song Y, Belin RJ, Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 2006; 1(5):351–355.
  • Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res 2007; 39(10):743–751.
  • Santana-Galvez J, Cisneros-Zevallos L, Jacobo-Velazquez DA. Chlorogenic acid: recent advances on its dual role as a food additive and a nutraceutical agaist metabolic syndrome. Molecules 2017; 22:358.
  • Maeda H. Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review. J Oleo Sci 2015; 64(2):125–132.
  • Millan J, Cicero AFG, Torres F, Anguera A. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta-analysis of randomized controlled trials. Clin Investig Arteriosclero 2016; 28 (4):178–187.
  • Ribas-Latre A, Eckel-Mahan K. Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic health. Mol Metab 2016; 5(3):133–152.
  • Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) 2015; 39(4):633–641.
  • Tarrade A, Panchenko P, Junien C, Gabory A. Placental contribution to nutritional programming of health and diseases: epigenetics and sexual dimorphism. J Exp Biol 2015; 218(Pt 1):50–58.
  • Brenseke B, Prater MR, Bahamonde J, Gutierrez JC. Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome. J Pregnancy 2013:368461.
  • Knip M, Akerblom HK.Early nutrition and later diabetes risk. Adv Exp Med Biol 2005; 569:142–150.
  • Brown LD. Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health. J Endocrinol 2014; 221(2): R13–29.
  • DeBoer MD, Lima AA, Oría RB, Scharf RJ, Moore SR, Luna MA, Guerrant RL. Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome? Nutr Rev 2012; 70(11):642–653.
  • Alvisi P, Brusa S, Alboresi S, Amarri S, Bottau P, Cavagni G, Corradini B, Landi L, Loroni L, Marani M, et al. Recommendations on complementary feeding for healthy, full-term infants. Ital J Pediatr 2015; 41:36.
  • Sun, C. H., et al. (2011). The effect of vitamin-mineral supplementation on CRP and IL-6: a systemic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 21(8):576–583. (Not referenced in the paper)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.